Fri Sep 20 12:15:51 UTC 2024: ## IQVIA Stock Gets a Boost: Analyst Upgrades and Strong Earnings Drive Positive Sentiment
**New York, NY -** IQVIA Holdings Inc (NYSE: IQV), a leading provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has seen its stock price target raised by analysts at Robert W. Baird, boosting investor confidence in the company.
The brokerage firm has increased its price target for IQVIA from $251.00 to $256.00, representing a potential upside of 4.65% from the company’s current price. Baird maintains a “neutral” rating on the stock.
This positive outlook comes on the heels of several other analysts expressing bullish sentiment towards IQVIA. The Goldman Sachs Group initiated coverage on the company with a “buy” rating and a $270.00 price target. Truist Financial also raised its price target from $292.00 to $300.00 and maintained a “buy” rating.
IQVIA’s strong second-quarter earnings report, released on July 22nd, further fueled optimism. The company reported earnings per share (EPS) of $2.64, exceeding analysts’ estimates by $0.07. Revenue for the quarter reached $3.81 billion, also surpassing expectations.
The company’s performance has attracted significant investor interest, with hedge funds like DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Morningstar Investment Services LLC, and Capital Research Global Investors increasing their stakes in IQVIA.
With a majority of analysts rating IQVIA as a “Moderate Buy,” and a positive outlook from several brokerage firms, the stock is positioned for continued growth.
First Piper 